PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 1, 2000European Journal of Clinical Investigation17 citations

Neuropeptide variability in man

View Full Paper
OOnuohaNNugentLHLeif Hunter

Structured PICO

Do circulating levels of vasoactive peptides (VIP, NPY, ET-1, CGRP) exhibit short-term variability in patients with chronic cardiac failure and normal cardiac function?

P
Population
Patients with chronic cardiac failure (CCF) and control subjects, as well as a second group of patients with normal cardiac function.
I
Intervention
Serial blood sampling at 2-minute intervals over a 20-minute period to measure immunoreactivity of vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY), endothelin-1 (ET-1), and calcitonin gene-related peptide (CGRP).
C
Comparator
Control subjects (for the CCF group).
O
Outcome
Variability (peaks and troughs) and overall circulating plasma levels of vasoactive peptides (VIP, NPY, ET-1, CGRP).surrogate

Circulating levels of neuropeptides like VIP, NPY, and ET-1 exhibit significant short-term pulsatile variability, suggesting that single measurements should be interpreted with caution.

Abstract

BACKGROUND: Previous studies have established short-term variability in the circulating plasma levels of cardiac peptides such as atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). Our aim was to investigate whether such variable patterns could be observed in other vasoactive peptides. METHODS: We measured the immunoreactivity of vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY), endothelin-1 (ET-1) and calcitonin gene-related peptide (CGRP) in peripheral venous plasma collected at 2-min intervals over a 20-min period from patients with chronic cardiac failure (CCF) and from control subjects. In a second study, blood samples were obtained at 2-min intervals from the pulmonary artery, femoral artery and antecubital vein from patients with normal cardiac function while right atrial pressure and heart rate were constant. RESULTS: Peripheral blood VIP, NPY and ET-1 had peaks and troughs (levels > 2SD from the mean) in both patients and controls, with approximate intervals of 10 min. Levels of CGRP showed little variation. The overall levels median (range); pmol L-1 of VIP patients 27 (2.1-85.5); controls 9.8 (0-34) and NPY patients 20 (0-110); controls 12 (5-19) were higher in patients (P < 0.05). Circulating plasma levels of ET-1 and CGRP were about the same in both groups ET-1: patients 18 (2-84); controls 18 (0-48); CGRP: patients 4 (1-18.5), controls 5.5 (1-15); P = NS. Levels of CGRP, VIP and ET-1 were similar in the pulmonary and femoral arteries, whereas systemic arterial levels of NPY were higher than in the pulmonary artery. CONCLUSIONS: The data demonstrate marked variability in circulating levels of the neuropeptides studied. In addition, peaks and troughs were observed every 10-15 min from all three vascular beds. If these peptides are secreted in a pulsatile pattern, then interpretations of single measurements should be guarded. Furthermore, this study raises interesting questions about the physiology of hormone secretion in man.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Onuoha et al. (2000) studied this question.

synapsesocial.com/papers/6a8be115f07ad6ed43b236cchttps://doi.org/10.1046/j.1365-2362.2000.00676.x
Ask AI
Helpful
Bookmark
Share
View Full Paper